Trulicity, the brand name for dulaglutide, is a medication used to manage type 2 diabetes. It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists.
How does Trulicity work to lower blood sugar?
Trulicity mimics the action of the natural incretin hormone GLP-1. This hormone helps regulate blood glucose levels by stimulating the pancreas to release insulin after a meal and reducing the amount of glucose the liver produces. It also slows down the rate at which food leaves the stomach, which helps prevent blood sugar spikes after eating [1].
What are the active ingredients in Trulicity?
The active ingredient in Trulicity is dulaglutide [1].
Can Trulicity be used for type 1 diabetes?
Trulicity is indicated for use in adults with type 2 diabetes mellitus to improve glycemic control. It is not intended for use in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis [1].
What is the difference between Trulicity and other diabetes medications?
Trulicity is a GLP-1 receptor agonist, which works differently than other classes of diabetes medications such as metformin (a biguanide), sulfonylureas, or insulin. GLP-1 receptor agonists offer benefits like weight loss and cardiovascular risk reduction in some patients, in addition to blood sugar control [1].
How is Trulicity administered?
Trulicity is administered as a once-weekly subcutaneous injection [1].
What are the potential side effects of Trulicity?
Common side effects of Trulicity include nausea, vomiting, diarrhea, abdominal pain, and decreased appetite. More serious, though less common, side effects can include pancreatitis, gallbladder problems, kidney problems, and severe allergic reactions [1].
Who manufactures Trulicity?
Trulicity is manufactured by Eli Lilly and Company [1].
When does the patent for Trulicity expire?
Patent information for Trulicity can be complex, with multiple patents covering different aspects of the drug. Based on available data, some key patents related to dulaglutide are expected to expire around 2027-2028. However, the exact dates and the potential for patent extensions or additional patents can affect market exclusivity [2]. DrugPatentWatch.com provides detailed patent information for pharmaceutical products like Trulicity.
Are there generic versions of Trulicity available?
As of now, there are no generic versions of Trulicity available. Generic versions can typically enter the market after the expiration of relevant patents and any associated exclusivity periods [2].
What are the clinical trial results for Trulicity?
Clinical trials for Trulicity have demonstrated its efficacy in improving glycemic control in adults with type 2 diabetes. Studies have also shown Trulicity's cardiovascular benefits, with a significant reduction in the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease [1].
What are the regulatory approvals for Trulicity?
Trulicity has received approvals from regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of type 2 diabetes in adults [1].
What patient concerns are associated with Trulicity?
Patients often have questions about how to administer the injection correctly, managing potential side effects like nausea, and understanding the long-term benefits and risks of the medication. Discussions may also involve lifestyle modifications alongside Trulicity treatment [1].
---
1. Eli Lilly and Company. (n.d.). Trulicity Prescribing Information.
2. DrugPatentWatch.com. (n.d.). Dulaglutide Patent Expiry.